Quantcast

Latest Anti-diabetic drug Stories

81b416161e923b00423da283a2c463d21
2008-09-24 08:39:04

A team of researchers has identified the active compounds that contribute to the health benefits of pre-germinated brown rice; the healthy components are a related set of sterol-like molecules known as acylated steryl-beta-glucosides (ASGs).

2008-09-22 06:00:30

Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced the initiation of the next phase of the preclinical safety program for AKP-020.

2008-09-16 06:00:10

GI Dynamics, a medical device company pioneering the development of new approaches to treat metabolic disorders, today announced new data regarding the EndoBarrier(TM), its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes.

2008-09-09 06:00:09

Results from a 24-week Phase III study presented at the 44th European Association for the Study of Diabetes Annual Meeting demonstrated that ONGLYZA(TM) (saxagliptin), an investigational selective inhibitor with extended binding to the dipeptidyl peptidase-4 (DPP-4) enzyme in development by Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN), when used in combination with metformin as an initial therapy, produced significant reductions across all key measures of glucose...

2008-09-08 09:00:08

Results from two 24-week Phase III studies presented at the 44th European Association for the Study of Diabetes Annual Meeting demonstrated that ONGLYZA(TM) (saxagliptin), an investigational selective inhibitor with extended binding to the dipeptidyl peptidase-4 (DPP-4) enzyme in development by Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN), produced significant reductions across all key measures of glucose control studied (glycosylated hemoglobin level (A1C), fasting...

2008-08-19 09:01:12

PALO ALTO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- Telik, Inc. announced today that it has entered into a license agreement with ReceptorBio, Inc. which would enable ReceptorBio to develop and commercialize Telik's oral small molecule insulin receptor activators.

2008-08-19 09:01:12

FOSTER CITY, Calif., Aug. 19 /PRNewswire-FirstCall/ -- ReceptorBio, Inc. announced today that it has entered into a license agreement with Telik, Inc. (Palo Alto, CA) that would enable ReceptorBio to develop and commercialize Telik's unique, oral small molecule insulin receptor activators.

2008-08-13 15:01:02

A wrongful death suit was filed against GlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in California Superior Court, charging that Avandia, prescribed for Type 2 Diabetes, led to heart attacks, congestive heart failure and other fatal cardiovascular injuries in seven individuals.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.